Immunotherapy in Upper Tract Urothelial Carcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

350

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2024

Conditions

Urothelial Carcinoma

Interventions

OTHER

Evaluation of anti-PD-(L)1 immunotherapy efficacy

Non Applicable, research on data

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT06113367 - Immunotherapy in Upper Tract Urothelial Carcinoma | Biotech Hunter | Biotech Hunter